CODEX+ CELIDA Recommendations
1.5.2 - ci-build
CODEX+ CELIDA Recommendations - Local Development build (v1.5.2) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
Active as of 2024-08-07 |
{
"resourceType" : "ActivityDefinition",
"id" : "TherapeuticAnticoagulationNMHTinzaparin",
"meta" : {
"profile" : [
🔗 "https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/StructureDefinition/drug-administration-action"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ActivityDefinition TherapeuticAnticoagulationNMHTinzaparin</b></p><a name=\"TherapeuticAnticoagulationNMHTinzaparin\"> </a><a name=\"hcTherapeuticAnticoagulationNMHTinzaparin\"> </a><a name=\"TherapeuticAnticoagulationNMHTinzaparin-en-US\"> </a><p><b>url</b>: <a href=\"ActivityDefinition-TherapeuticAnticoagulationNMHTinzaparin.html\">ActivityDefinition Therapeutic Anticoagulation Treatment with Tinzaparin</a></p><p><b>version</b>: 0.1</p><p><b>name</b>: TherapeuticAnticoagulationPlanTinzaparin</p><p><b>title</b>: Therapeutic Anticoagulation Treatment with Tinzaparin</p><p><b>status</b>: Active</p><p><b>experimental</b>: true</p><p><b>subject</b>: <span title=\"Codes:{http://hl7.org/fhir/fhir-types Patient}\">Patient</span></p><p><b>date</b>: 2024-08-07 14:55:39+0000</p><p><b>publisher</b>: NUM CODEX+ CELIDA</p><p><b>description</b>: </p><div><p>Therapeutic Anticoagulation Treatment (NMH) for non-intensive care hospitalised COVID-19 patients patients with high risk (D-Dimer >= 2mg/l) with Tinzaparin</p>\n</div><p><b>kind</b>: MedicationRequest</p><p><b>code</b>: <span title=\"Codes:{http://snomed.info/sct 432102000}\">Administration of substance (procedure)</span></p><p><b>product</b>: <span title=\"Codes:{http://snomed.info/sct 412608008}, {http://fhir.de/CodeSystem/bfarm/atc B01AB10}\">Tinzaparin (substance)</span></p><blockquote><p><b>dosage</b></p></blockquote></div>"
},
"extension" : [
{
"url" : "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-knowledgeCapability",
"valueCode" : "computable"
},
{
"url" : "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-knowledgeRepresentationLevel",
"valueCode" : "structured"
}
],
"url" : "https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommended-action/drug-administration-action/therapeutic-anticoagulant-tinzaparin-administration",
"version" : "0.1",
"name" : "TherapeuticAnticoagulationPlanTinzaparin",
"title" : "Therapeutic Anticoagulation Treatment with Tinzaparin",
"status" : "active",
"experimental" : true,
"subjectCodeableConcept" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/fhir-types",
"code" : "Patient"
}
]
},
"date" : "2024-08-07T14:55:39+00:00",
"publisher" : "NUM CODEX+ CELIDA",
"description" : "Therapeutic Anticoagulation Treatment (NMH) for non-intensive care hospitalised COVID-19 patients patients with high risk (D-Dimer >= 2mg/l) with Tinzaparin",
"kind" : "MedicationRequest",
"code" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "432102000",
"display" : "Administration of substance (procedure)"
}
]
},
"productCodeableConcept" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "412608008",
"display" : "Tinzaparin (substance)"
},
{
"system" : "http://fhir.de/CodeSystem/bfarm/atc",
"code" : "B01AB10",
"display" : "Tinzaparin"
}
]
},
"dosage" : [
{
"timing" : {
"repeat" : {
"frequency" : 1,
"period" : 1,
"periodUnit" : "d"
}
},
"route" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "34206005",
"display" : "Subcutaneous route (qualifier value)"
}
]
},
"doseAndRate" : [
{
"doseQuantity" : {
"value" : 175,
"unit" : "IU/kg",
"system" : "http://unitsofmeasure.org",
"code" : "[iU]/kg"
}
}
]
}
]
}